Samir Taneja, MD
The use of MRI scans to detect and treat prostate cancer more effectively continues to be a growing area of investigation, according to Samir Taneja, MD.
on Genitourinary Cancers, Taneja, director, Urologic Oncology, Genito-Urologic program leader, NYU Langone’s Perlmutter Cancer Center, discussed his research on MRI-guided prostate biopsies and other modalities in development.
OncLive: Can you provide an overview of your presentation?
: My research really has focused on the idea of using imaging to change the way we diagnose the disease, risk-assess prostate cancer, select treatments, and even the way we've started to treat it in order to reduce some of the side effects that men experience when they go through conventional therapy. We started thinking we could see the cancer before we biopsy it, very similar to the way a woman gets a mammogram before she gets a biopsy.
... to read the full story